SEC Form 4 · accession 0001209191-15-062426
Tracon Pharmaceuticals, Inc. · TCON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William R Larue
Director
Period of report
Jul 23, 2015
Accepted (ET)
Jul 24, 2015 · 6:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001394319
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option ( Right to Buy)F1 | $13.02 | Jul 23, 2015 | A | 15,000 | A | — | Jul 22, 2025 | Common Stock | 15,000 | 15,000 | D |
| Director Stock Option ( Right to Buy)F2 | $13.02 | Jul 23, 2015 | A | 12,547 | A | — | Jul 22, 2025 | Common Stock | 12,547 | 12,547 | D |
Explanation of responses
- F1The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders.
- F2One-third of the shares subject to the stock option shall vest and become exercisable annually on the anniversary of the vesting commencement date of July 23, 2014.